Quent Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.2K Sell
67
-27
-29% -$9.19K ﹤0.01% 959
2025
Q4
$37.4K Buy
94
+9
+11% +$3.98K ﹤0.01% 829
2025
Q3
$38.8K Buy
+85
New +$34.6K ﹤0.01% 672
2025
Q2
Sell
-17
Closed -$4.59K 324
2025
Q1
$4.59K Hold
17
﹤0.01% 1031
2024
Q4
$4K Buy
17
+1
+6% +$263 ﹤0.01% 1083
2024
Q3
$4.4K Hold
16
﹤0.01% 1123
2024
Q2
$3.89K Sell
16
-155
-91% -$24.5K ﹤0.01% 1124
2024
Q1
$25.6K Sell
171
-2
-1% -$334 ﹤0.01% 818
2023
Q4
$33.1K Buy
173
+123
+246% +$21K ﹤0.01% 720
2023
Q3
$8.86K Sell
50
-8
-14% -$1.53K ﹤0.01% 956
2023
Q2
$11K Hold
58
﹤0.01% 916
2023
Q1
$11.6K Buy
58
+50
+625% +$10.5K ﹤0.01% 892
2022
Q4
$1.9K Buy
+8
New +$1.71K ﹤0.01% 1159

Other funds holding ALNY